We use cookies to ensure that we give you the best experience on our website Learn more

Home

Saved research

Conference

Global Congress on Prostate Cancer 2020

October 10-14, 2020 · Online

25 submissions

SUBMISSION

Treatment sequencing in metastatic castration resistant prostate cancer (mCRPC) after progression under an androgen receptor signaling inhibitor (ARSI) and to docetaxel: results in long responders to previous ARSIs

gil falcao

SUBMISSION

Castration-resistant prostate cancer - Cabazitaxel as a rescue

gil falcao

SUBMISSION

Treatments sequencing in metastatic prostate cancer new diagnosed: more opportunities in progression free survival. A case report

Marta Jiménez Navarro

abiraterone acetate

and 2 more

SUBMISSION

Validating SGK1 as a Therapeutic Target in Prostate Cancer

Luke Ginnelly

Validating

and 20 more

SUBMISSION

Overall Survival, Disease Progression, and Quality of Life of Metastatic CRPC patient on Enzalutamide Treatment

Donny Eka Putra and 1 other

CRPC

and 3 more

SUBMISSION

Chemoprevention of carcinogen-induced prostate cancer by polyprenols from coniferous trees: experimental study

Murazov Yaroslav and 4 other

prostate cancer

and 3 more

SUBMISSION

Symptomatic peritoneal carcinomatosis as the initial presentation of metastatic prostate cancer

João Paulo Baptista Godinho and 6 other

Prostate Cancer

and 1 more

SUBMISSION

About a case highlighting the place of metastasis-directed therapy in isolated liver metastases in prostate cancer

Anne-Emmanuella YEO and 5 other

prostate cancer

and 3 more

SUBMISSION

Prostate cancer in Maroni area, French Guiana: the lack of access to health facilities penalizes patients

Jean-Pierre Droz and 2 other

SUBMISSION

Factors predicting outcome with multi-rsistant advanced prostate cancer treated with prostate specific membrane antigen radioligand therapy. A systematic review and meta-analysis

Finn Edler von Eyben

Prostate cancer

and 4 more

SUBMISSION

Outcomes of high-risk prostate cancer after robotic-assisted radical prostatectomy: Real-life experience

Luísa Jerónimo Alves

high-risk prostate cancer

SUBMISSION

Abiraterone acetate withdrawal syndrome in metastatic castration-resistant prostate cancer (mCRPC)

Pedro Simões and 8 other

Abiraterone

and 7 more

SUBMISSION

Treatment of castration-resistant prostate cancer

Luísa Leal-Costa and 6 other

Prostate Cancer

and 2 more

SUBMISSION

Impact of modern imaging tools on management of prostate cancer, a single center evaluation.

Guillaume Grisay and 1 other

prostate cancer

and 3 more

SUBMISSION

Detection rate of clinically significant cancer using magnetic resonance imaging/ultrasound cognitive-fusion prostate biopsy

Sarah Silverman and 1 other

clinically significant prostate cancer

and 3 more

SUBMISSION

Prostate ultrahypofractionation in the COVID-19 era: potential impact on a UK centre

William Griffiths and 5 other

Prostate Cancer

and 4 more

SUBMISSION

Isolated peritoneal carcinomatosis in prostate cancer, maybe not so rare. About a case highlighting the importance of modern imaging and efficacy of abiraterone acetate.

Delchambre Emilie and 2 other

prostate cancer

and 3 more

SUBMISSION

Neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and its kinetics as prognostic markers for patients with metastatic castration resistant prostate cancer treated with Enzalutamide

Rita Sofia Vitorino da Silva Paiva

biomarkers

and 1 more

SUBMISSION

THE PATHOLOGICAL FEATURES OF PROSTATE CANCER IN SOUTH AFRICAN MEN: WHAT IS THE PREVALENCE OF LOCAL INVASION AT DIAGNOSIS?

Kgomotso Mathabe and 2 other

prostate cancer

and 1 more

SUBMISSION

Final overall survival (OS) analysis of PROfound: olaparib vs physician's choice of enzalutamide or abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations

Antoine Theiry-Vuillemin

Winner

SUBMISSION

PATIO - empowering prostate cancer patients in science

Marie Niederleithinger and 4 other

prostate cancer

and 3 more

SUBMISSION

Optimization of PET protocol and interrater reliability of 18F-PSMA-11 imaging of prostate cancer

Sarah Piron

prostate cancer

and 5 more

SUBMISSION

Rate of adverse morphological features after radical prostatectomy

Andrei Petrashevskii

SUBMISSION

Non-coding mitochondrial RNAs as target for development of potent therapy against prostate cancer

Jaime Villegas Olavarría

1 2

Company

Legal

Home About Contact

Imprint Terms of Service Privacy Policy